The Johns Hopkins tradition of innovation and discovery extends to patients at Johns Hopkins Singapore International Medical Centre who elect to participate in research studies called clinical trials. The aim is to find new therapies or more effective ways of using known treatments. Clinical and translational research is currently being conducted on new agents and innovative therapies on breast cancer, lung cancer, nasopharyngeal cancer, and hepatocellular cancer.
Johns Hopkins Singapore International Medical Centre is part of the Cancer Therapeutics Research Group (CTRG) that,a research collaboration between the National University Hospital (NUH), National University of Singapore (NUS), Sydney Cancer Centre / University of Sydney, Johns Hopkins Singapore International Medical Centre, Chinese University of Hong Kong and National Cancer Please click here for more information on clinical trials.
Johns Hopkins Singapore International Medical Centre is committed to finding new and more effective treatments for patients with cancer through an active clinical trials program.
You may find a list of our studies that we currently open enrollment here.
If you are interested in participating in a clinical trial at Johns Hopkins Singapore International Medical Centre, please email us at trial@imc.jhmi.edu.
|
